J Korean Med Assoc.  2011 Dec;54(12):1289-1296. 10.5124/jkma.2011.54.12.1289.

Vaccination necessary for Korean adults

• Cheong HJ

• KMID: 2064780
• DOI: http://doi.org/10.5124/jkma.2011.54.12.1289

Abstract

The Korean Society of Infectious Diseases has provided vaccination schedules for adults residing in Korea since 2007. The primary goal of adult immunization is to maintain effective immunization coverage lasting into old age and to protect from opportunistic infections during the aging process. All adults should receive at least a decennial booster vaccination against diphtheria and tetanus as well as pertussis. Individuals above the age of 65 additionally benefit from vaccinations against pneumococcus. Even though everyone can get an annual influenza vaccine, the elderly population and persons who have chronic disease are considered the preferred group. Human papilloma virus vaccine is recommended for women under 26 years old as a catch-up vaccination. Universal hepatitis A vaccination might be helpful for persons in their 20s as a control measure nowadays under the hepatitis A epidemic. We carefully consider meningococcal vaccination for the military recruits and college student in dormitories. Furthermore, we should consider special vaccination for travelers or pregnant women. To assess vaccine benefits and risks, vaccination providers should understand the most effective strategies to reduce the burden of vaccine-preventable disease according to host status.

Keyword

Vaccination; Adult

MeSH Terms

Adult
Aged
Aging
Appointments and Schedules
Chronic Disease
Collodion
Communicable Diseases
Diphtheria
Female
Hepatitis A
Humans
Immunization
Influenza Vaccines
Korea
Military Personnel
Opportunistic Infections
Papilloma
Pregnant Women
Risk Assessment
Streptococcus pneumoniae
Tetanus
Vaccination
Viruses
Whooping Cough
Collodion
Influenza Vaccines

Reference

1. Gardner P, Schaffner W. Immunization of adults. N Engl J Med. 1993. 328:1252–1258.

2. Choi JH, Kang JH. Korean Society of Infectious Disease. Tetanus vaccine. Vaccination for adult. 2007. 1st ed. Seoul: Koonja Press;35–44.

3. Choi JH, Choo EJ, Huh A, Choi SM, Eom JS, Lee JS, Park SH, Kang JH. Immunogenicity and safety of diphtheria-tetanus vaccine in adults. J Korean Med Sci. 2010. 25:1727–1732.

4. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011. 60:1128–1132.

5. Lee H, Cho HK, Kim JH, Kim KH. Seroepidemiology of hepatitis A in Korea: changes over the past 30 years. J Korean Med Sci. 2011. 26:791–796.

6. Sim JG, Seo JK, Suh SJ. Prevalence and its changes of hepatitis B viral markers from 1988 to 1993 in Korean children. J Korean Pediatr Soc. 1995. 38:1535–1539.

7. Yim HJ, Chang YJ, Byun KS, Suh YS, Kim JH, Kim JY, Yeon JE, Park JJ, Kim JS, Bak YT, Lee CH. The changing patterns of acute hepatitis B infection in Korea in the early 2000's. Korean J Med. 2005. 69:601–607.

8. Gardasil: human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant [Internet]. 2009. cited 2011 Nov 14. Silver Spring (MD): U.S. Food and Drug Administration;Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM111263.pdf.

9. Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G. HPV PATRICIA Study Group. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomized study in young women. Lancet. 2009. 374:301–314.

10. Lim J, Eom CS, Kim S, Ke S, Cho B. Pneumococcal vaccination rate among elderly in South Korea. J Korean Geriatr Soc. 2010. 14:18–24.

11. Bae SM, Kang YH. Serological and genetic characterization of meningococcal isolates in Korea. Jpn J Infect Dis. 2008. 61:434–437.